Huntington National Bank decreased its stake in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 3.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,293 shares of the business services provider’s stock after selling 263 shares during the period. Huntington National Bank’s holdings in Exponent were worth $841,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Vanguard Group Inc. lifted its stake in shares of Exponent by 5.8% in the 1st quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock worth $437,153,000 after acquiring an additional 291,047 shares during the period. Kayne Anderson Rudnick Investment Management LLC lifted its holdings in shares of Exponent by 6.5% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider’s stock valued at $441,414,000 after purchasing an additional 284,179 shares during the last quarter. Conestoga Capital Advisors LLC increased its position in shares of Exponent by 1.6% in the third quarter. Conestoga Capital Advisors LLC now owns 2,806,517 shares of the business services provider’s stock worth $323,535,000 after acquiring an additional 43,257 shares in the last quarter. Geneva Capital Management LLC lifted its holdings in shares of Exponent by 1.7% in the third quarter. Geneva Capital Management LLC now owns 1,590,804 shares of the business services provider’s stock valued at $183,388,000 after purchasing an additional 27,339 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in Exponent by 0.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,019,085 shares of the business services provider’s stock worth $96,937,000 after acquiring an additional 6,108 shares during the period. Institutional investors and hedge funds own 92.37% of the company’s stock.
Wall Street Analyst Weigh In
Separately, Truist Financial reissued a “buy” rating and issued a $120.00 target price (up from $100.00) on shares of Exponent in a research report on Friday, July 26th.
Insider Activity at Exponent
In related news, Director Carol Lindstrom sold 1,039 shares of Exponent stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $96.32, for a total value of $100,076.48. Following the sale, the director now owns 5,871 shares of the company’s stock, valued at approximately $565,494.72. This trade represents a 15.04 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Paul R. Johnston sold 14,000 shares of the company’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $104.60, for a total value of $1,464,400.00. Following the sale, the director now owns 80,742 shares in the company, valued at $8,445,613.20. The trade was a 14.78 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 22,039 shares of company stock valued at $2,291,286 over the last quarter. Corporate insiders own 2.10% of the company’s stock.
Exponent Trading Down 1.2 %
NASDAQ EXPO opened at $97.40 on Friday. The stock’s 50 day moving average is $107.23 and its two-hundred day moving average is $101.97. Exponent, Inc. has a 1-year low of $68.70 and a 1-year high of $115.75. The company has a market capitalization of $4.94 billion, a price-to-earnings ratio of 47.05 and a beta of 0.69.
Exponent Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Friday, December 6th will be issued a $0.28 dividend. The ex-dividend date of this dividend is Friday, December 6th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.15%. Exponent’s dividend payout ratio is 54.11%.
Exponent Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading
- Five stocks we like better than Exponent
- How Can Investors Benefit From After-Hours Trading
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Top-Performing Non-Leveraged ETFs This Year
- Do ETFs Pay Dividends? What You Need to Know
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.